New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...

Eli Lilly & Co.’s experimental weight-loss pill helped patients shed pounds without serious side effects in a clinical trial, burnishing the drug’s blockbuster potential in the company’s competition ...

The new Ozempic? Weight-loss pill Amycretin could be more effective than jabs - Those who took the pill lost around 13 per cent of their body weight over three months ...

Found a stray pill in your medicine cabinet? Have a loved one who mixed up a couple of their meds by mistake? There are plenty of reasons you might wonder, “What pill is this?” WebMD’s Pill ...

(Reuters) - Eli Lilly is betting big on its experimental oral weight-loss ... Novo is studying the pill version of its experimental drug, amycretin, while others including AstraZeneca are also ...

By Sriparna Roy (Reuters) - Eli Lilly (NYSE: LLY) is betting big on its experimental oral weight-loss drug even before reporting data from its late-stage trial by recording nearly $550 million in ...